CurAccel was formed in 2012 as the quality management service division of Excelsior Scientific Research, a global clinical research organization. Since our inception, we stand on the principle of performing and managing clinical trials with the quality standards expected by our clients and regulatory authorities. After working with biotechnology and pharmaceutical companies, CurAccel has been established as a global clinical research organization.
Bringing together the best and brightest clinical research professionals, CurAccel has advised clients to deliver maximum value in their drug and device development strategies.
CurAccel is a minority women-owned CRO that combines its expertise in site management and patient management solutions to create operational efficiencies that enhance quality, productivity, and timely delivery of research projects. Our model has reduced timelines 25% to 75% from original targets and delivered Sponsors on average a 20%-30% savings in overall project costs when compared to industry standard pricing because of our integrated offerings. Most importantly, our clients are very pleased; demonstrating their satisfaction by awarding us repeat business – 91% in the last 3 years and serving as client references.